HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Treatment strategy for malignant solid tumors in childhood].

Abstract
The prognosis for children with malignant solid tumors has improved dramatically in Japan. During the last two decades, various groups have conducted sequential studies of the treatment of children with neuroblastoma, Wilms' tumor, and hepatoblastoma. Most institutes participated in nonrandomized trials designed to evaluate the safety and efficacy of combination chemotherapy, surgery, and radiotherapy in each group study and treated children with these tumors The results are reviewed and areas for future investigation are identified.
AuthorsNaomi Ohnuma, Hideo Yoshida, Tadashi Matsunaga, Katsunori Kouchi, Tomoro Hishiki, Shinichi Yamada, Yoshiharu Satoh, Keita Terui
JournalNihon Geka Gakkai zasshi (Nihon Geka Gakkai Zasshi) Vol. 106 Issue 7 Pg. 413-7 (Jul 2005) ISSN: 0301-4894 [Print] Japan
PMID16045183 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Neoplasm Proteins
Topics
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Child
  • Child, Preschool
  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Humans
  • Infant
  • Infant, Newborn
  • Neoplasm Proteins (genetics)
  • Neoplasms (genetics, therapy)
  • Prognosis
  • Radiotherapy Dosage
  • Surgical Procedures, Operative

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $490.00 USD